Plasma orexin-A levels in postmenopausal women: Possible interaction with estrogen and correlation with cardiovascular risk status

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 4, 2010, Pages 488-492

  El Sedeek, Mshea ^a   Korish, A A ^a   Deef, M M ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Cardiovascular disease; Estrogen; Hypertension; Menopause; Orexin

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTRADIOL; GLUCOSE; NORGESTREL; OREXIN A; PREMPAK; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; OREXIN A BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL; ESTROGENS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; NEUROPEPTIDES; POSTMENOPAUSE; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES;

EID: 76349098452     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2009.02474.x     Document Type: Article

References (27)

1. Schneider JE. Energy balance and reproduction. Physiol Behav 2004 81 : 289 317.
2. Mircea CN, Lujan ME, Pierson RA. Metabolic fuel and clinical implications for female reproduction. J Obstet Gynaecol Can 2007 29 : 887 902.
3. Wade GN, Jones JE. Neuroendocrinology of nutritional infertility. Am J Physiol Regul Integr Comp Physiol 2004 287 : R1277 96.
4. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 2001 24 : 429 458.
5. Kukkonen JP, Holmqvist T, Ammoun S, Akerman KE. Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 2002 283 : C1567 91.
6. Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008 1129 : 287 304.
7. Adam JA, Menheere PP, van Dielen FM, Soeters PB, Buurman WA, Greve JW. Decreased plasma orexin-A levels in obese individuals. Int J Obes Relat Metab Disord 2002 26 : 274 276.
8. Heinonen MV, Purhonen AK, Mäkelä KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol (Oxf) 2008 192 : 471 485.
9. Digby JE, Chen J, Tang JY, Lehnert H, Matthews RN, Randeva HS. Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J Endocrinol 2006 191 : 129 136.
10. Snow A, Gozal E, Malhotra A, Tiosano D, Perlman R, Vega C, et al. Severe hypersomnolence after pituitary/hypothalamic surgery in adolescents: clinical characteristics and potential mechanisms. Pediatrics 2002 110 : e74.
11. Colditz GA, Willett WC, Stamfer MJ. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987 316 : 1105 1110.
12. Saleh Mc, Connell BJ, Saleh TM. Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res 2000 879 : 105 114.
13. Russell SH, Small CJ, Kennedy AR, Stanley SA, Seth A, Murphy KG, et al. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 2001 142 : 5294 5302.
14. Campbell RE, Kevin L, Grove KL, Smith SM. Gonadotropin-releasing hormone neurons coexpress orexin 1 receptor immunoreactivity and receive direct contacts by orexin fibers. Endocrinology 2003 144 : 1542 1548.
15. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991 265 : 1861 1867.
16. Staessen J, Bulpitt CJ, Fagard R. The influence of menopause on blood pressure. J Hum Hypertens 1989 3 : 427 433.
17. Vongpatanasin W, Tuncel M, Mansour Y. Transdermal estrogen replacement therapy decreases sympathetic activity in post menopausal women. Circulation 2001 103 : 2903 2908.
18. Weitz G, Elam M, Born J. Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J Clin Endocrinol Metab 2001 86 : 344 348.
19. Shirasaka T, Takasaki M, Kannan H. Cardiovascular effects of leptin and orexins. Am J Physiol Regul Integr Comp Physiol 2003 284 : R639 51.
20. Barazanji KA, Wilson S, Baker J, Jessop DS, Harbuz MS. Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J Neuroendocrinol 2001 13 : 421 424.
21. Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P. Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 2001 142 : 3324 3331.
22. Shiraska T, Nakazato S, Matsukura M, Takasaki H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 1999 277 : R1780 5.
23. Taylor MM, Samson WK. The other side of the orexins: endocrine and metabolic actions. Am J Physiol Endocrinol Metab 2003 284 : E13 7.
24. Nowak KW, Mackowiak P, Switonska MM, Fabis M, Malendowicz LK. Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci 2000 66 : 449 454.
25. Schuld A, Hebebrand J, Geller F, Pollmaecher T. Increased body-mass index in patients with narcolepsy. Lancet 2000 355 : 1274 1275.
26. Honda Y, Doi Y, Nimomiya R, Ninomiya C. Increased frequency of non-insulin diabetes mellitus among narcoleptic patients. Sleep 1986 9 : 254 259.
27. Baranowska B, Wolińska-Witort E, Martyńska L, Chmielowska M, Baranowska-Bik A. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuro Endocrinol Lett. 2005 26 : 293 296.